Prof Prudence A. Francis
Clinical (Professor)
The Sir Peter MacCallum Department of Oncology
257 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
CAPTURE: A phase II trial evaluating alpelisib fulvestrant vs capecitabine in advanced breast cancer patients with PIK3CA-mutant circulating DNA following CDK4/6 inhibition.
DOI: 10.1200/JCO.2026.44.16_suppl.10642026
Journal article
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
DOI: 10.1016/j.annonc.2026.05.7042026
Journal article
275P 15-year incidence of invasive local, regional or contralateral events as first subsequent breast cancer event among HR premenopausal patients in SOFT and TEXT
DOI: 10.1016/j.esmoop.2026.1072272026
Journal article
Identifying premenopausal patients with early-stage hormone receptor–positive breast cancer at minimal risk of distant recurrence by breast cancer index
DOI: 10.1016/j.breast.2026.1047142021
Journal article
Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
DOI: 10.1093/jnci/djab1112021
Research Grant
Understanding Response to Neoadjuvant Therapy in Hormone Receptor Positive Breast Cancer: A Correlative Analysis of the ELIMINATE Trial
2018
Research Grant
Capture: Circulating Tumour Dna Assessment of Pik3ca to Guide Treatment Response
RECENT SCHOLARLY WORKS
2026
Journal article
A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast Cancer
DOI: 10.1002/pon.704182026
Journal article
Abstract PS3-07-27: Identifying Premenopausal Patients with Early-Stage Hormone Receptor-Positive Node-Negative Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index
DOI: 10.1158/1557-3265.sabcs25-ps3-07-272026
Journal article
Abstract PS5-04-07: Real world experience with trastuzumab deruxtecan for metastatic breast cancer at a major Australian cancer centre
DOI: 10.1158/1557-3265.sabcs25-ps5-04-072026
Journal article
Abstract PD7-10: Neo-n (neon): three-year event-free survival and ultrasensitive ctdna dynamics in early triple-negative breast cancer (tnbc) treated with neoadjuvant carboplatin/paclitaxel and nivolumab
DOI: 10.1158/1557-3265.sabcs25-pd7-102026
Journal article
Evaluating the Sleep Cancer Rest (SleepCaRe) Trial for Improving Health-Related Quality of Life (HRQoL) in Women Undergoing Chemotherapy for Breast Cancer - A Randomised Controlled Trial
DOI: 10.1016/j.sleep.2025.1083512026
Journal article
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer
DOI: 10.1056/NEJMoa2511218
RECENT PROJECTS
2016
Research Grant
Randomised Phase Iii Trial of Adjuvant Radiotherapy Versus Observation Following Breast Conserving Surgery and Endocrine Therapy in Patients With Molecularly Characterised Low-Risk Luminal a Early Breast Cancer
2015
Research Grant
The Landscape of Cancer Genes and Associations With Prognosis in Breast Cancer Diagnosed in Premenopausal Women